These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 38098097)
21. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma. Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL Front Immunol; 2021; 12():781087. PubMed ID: 35069553 [TBL] [Abstract][Full Text] [Related]
22. The panoramic picture of pepsinogen gene family with pan-cancer. Shen S; Li H; Liu J; Sun L; Yuan Y Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881 [TBL] [Abstract][Full Text] [Related]
23. Pan-cancer Analysis of the Disulfidptosis-related Gene NCKAP1 and Its Prognostic Value for Lung Adenocarcinoma. Zhu A; Zong Y; Wei S; Li Y; Fan Y; Liu S; Gao X J Cancer; 2023; 14(17):3351-3367. PubMed ID: 37928421 [TBL] [Abstract][Full Text] [Related]
24. ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: a pan-cancer analysis. Lin Y; Zhang Y; Tuo Z; Gao L; Ding D; Bi L; Yu D; Lv Z; Wang J; Chen X BMC Cancer; 2023 Mar; 23(1):285. PubMed ID: 36978046 [TBL] [Abstract][Full Text] [Related]
25. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma. Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633 [TBL] [Abstract][Full Text] [Related]
26. Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma. Luan H; Zhang C; Zhang T; He Y; Su Y; Zhou L Dis Markers; 2020; 2020():8825997. PubMed ID: 32934754 [TBL] [Abstract][Full Text] [Related]
27. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression. Chen X; Yuan Y; Ren W; Zhou F; Huang X; Pu J; Niu X; Jiang X Front Oncol; 2022; 12():927988. PubMed ID: 35756681 [TBL] [Abstract][Full Text] [Related]
28. NALCN is a potential biomarker and therapeutic target in human cancers. He J; Xu J; Chang Z; Yan J; Zhang L; Qin Y Front Genet; 2023; 14():1164707. PubMed ID: 37152978 [No Abstract] [Full Text] [Related]
29. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma. Hao YP; Wang WY; Qiao Q; Li G Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884 [TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2. Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y Front Immunol; 2023; 14():1155182. PubMed ID: 37275857 [TBL] [Abstract][Full Text] [Related]
31. Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy. Jia Y; Guo B; Zhang W; Wang F; Zhang Y; Zhang Q; Li E Front Oncol; 2023; 13():1110207. PubMed ID: 37427102 [TBL] [Abstract][Full Text] [Related]
32. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma. Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355 [TBL] [Abstract][Full Text] [Related]
33. ACBD3 Is an Essential Pan-enterovirus Host Factor That Mediates the Interaction between Viral 3A Protein and Cellular Protein PI4KB. Lyoo H; van der Schaar HM; Dorobantu CM; Rabouw HH; Strating JRPM; van Kuppeveld FJM mBio; 2019 Feb; 10(1):. PubMed ID: 30755512 [TBL] [Abstract][Full Text] [Related]
34. A Pan-Cancer Analysis of the Oncogenic Role of Yang D; Li H; Chen Y; Li C; Ren W; Huang Y Front Genet; 2022; 13():906174. PubMed ID: 35910232 [No Abstract] [Full Text] [Related]
35. Pan-cancer analysis of the prognostic and immunological role of BRCA1-associated protein 1 gene (BAP1): Friend or foe? Wang T; Zhu T; Zhang Y; Bai J; Xue Y; Xu G; Lu L; Peng Q Gene; 2022 Oct; 840():146765. PubMed ID: 35905855 [TBL] [Abstract][Full Text] [Related]
36. Comprehensive Analysis of Liu J; Zhu B; Chen J; Cao Y Anticancer Res; 2023 Oct; 43(10):4491-4509. PubMed ID: 37772558 [TBL] [Abstract][Full Text] [Related]
37. Multiomics data identifies RSPO2 as a prognostic biomarker in human tumors associated with pan-cancer. Srivastava A; Srivastava S Adv Protein Chem Struct Biol; 2024; 139():469-499. PubMed ID: 38448143 [TBL] [Abstract][Full Text] [Related]
38. PANX1 is a potential prognostic biomarker associated with immune infiltration in pancreatic adenocarcinoma: A pan-cancer analysis. Bao L; Sun K; Zhang X Channels (Austin); 2021 Dec; 15(1):680-696. PubMed ID: 34796785 [TBL] [Abstract][Full Text] [Related]
39. Exercise-induced IL-15 acted as a positive prognostic implication and tumor-suppressed role in pan-cancer. Luo Z; He Z; Qin H; Chen Y; Qi B; Lin J; Sun Y; Sun J; Su X; Long Z; Chen S Front Pharmacol; 2022; 13():1053137. PubMed ID: 36467072 [No Abstract] [Full Text] [Related]
40. Systematic Analysis of the Prognostic Significance and Roles of the Integrin Alpha Family in Non-Small Cell Lung Cancers. Huang Y; Guo DM; Bu S; Xu W; Cai QC; Xu J; Jiang YQ; Teng F Adv Ther; 2023 May; 40(5):2186-2204. PubMed ID: 36892810 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]